Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Rev. bras. farmacogn ; 28(5): 602-609, Sept.-Oct. 2018. tab, graf
Article in English | LILACS | ID: biblio-977727

ABSTRACT

Abstract Annona leptopetala (R.E.Fr.) H. Rainer, Annonaceae, is used in folk medicine like antitumor and anti-inflammatory. The aim of this study was to determine chemical composition, toxicity and antitumor activity of A. leptopetala leaves volatile oil. Fresh leaves were hydrodistilled and then the volatile oil chemical composition was assessed by gas chromatography and mass spectrometry. Toxicity was assessed using haemolysis, micronucleus and acute toxicity protocols. Antitumor effects were determined in vitro and in vivo, using sulforhodamine B assay and sarcoma 180 murine tumor model, respectively. Spathulenol was the major component identified (12.56%). The volatile oil showed in vitro antitumor activity mainly in leukemia cell line (K-562), with Total growth inhibit (TGI) (concentration producing TGI) of 0.64 µg/ml. In other hand, the volatile oil <250 µg/ml did not inhibit HaCat non-tumor cell line growth. The concentration that produced 50% haemolysis was 372.8 µg/ml. The 50% lethal dose in mice was approximately 447.2 mg/kg intraperitoneally. Sarcoma 180 tumor growth inhibition rates were 59.29% and 58.77% at 100 and 150 mg/kg intraperitoneally, respectively. The volatile oil presented moderate gastrointestinal toxicity and no genotoxicity was observed at 350 mg/kg. Thus, the volatile oil shows antitumor activity with moderate toxicity.

3.
BMC Complement Altern Med ; 17(1): 347, 2017 Jul 03.
Article in English | MEDLINE | ID: mdl-28673306

ABSTRACT

BACKGROUND: The essential oil from Mesosphaerum sidifolium (L'Hérit.) Harley & J.F.B.Pastore (syn. Hyptis umbrosa), Lamiaceae (EOM), and its major component, have been tested for toxicity and antitumor activity. METHODS: EOM was obtained from aerial parts of M. sidifolium subjected to hydro distillation, and gas chromatography-mass spectrometry was used to characterize the EOM chemical composition. The toxicity was evaluated using haemolysis assay, and acute toxicity and micronucleus tests. Ehrlich ascites carcinoma model was used to evaluate the in vivo antitumor activity and toxicity of EOM (50, 100 and 150 mg/kg), and fenchone (30 and 60 mg/kg) after 9 d of treatment. RESULTS: The EOM major components were fenchone (24.8%), cubebol (6.9%), limonene (5.4%), spathulenol (4.5%), ß-caryophyllene (4.6%) and α-cadinol (4.7%). The HC50 (concentration producing 50% haemolysis) was 494.9 µg/mL for EOM and higher than 3000 µg/mL for fenchone. The LD50 for EOM was approximately 500 mg/kg in mice. The essential oil induced increase of micronucleated erythrocytes only at 300 mg/kg, suggesting moderate genotoxicity. EOM (100 or 150 mg/kg) and fenchone (60 mg/kg) reduced all analyzed parameters (tumor volume and mass, and total viable cancer cells). Survival also increased for the treated animals with EOM and fenchone. For EOM 150 mg/kg and 5-FU treatment, most cells were arrested in the G0/G1 phase, whereas for fenchone, cells arrested in the S phase, which represents a blockage in cell cycle progression. Regarding the toxicological evaluation, EOM induced weight loss, but did not induce hematological, biochemical or histological (liver and kidneys) toxicity. Fenchone induced decrease of AST and ALT, suggesting liver damage. CONCLUSIONS: The data showed EOM caused in vivo cell growth inhibition on Ehrlich ascites carcinoma model by inducing cell cycle arrest, without major changes in the toxicity parameters evaluated. In addition, this activity was associated with the presence of fenchone, its major component.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Carcinoma, Ehrlich Tumor/drug therapy , Lamiaceae/chemistry , Norbornanes/administration & dosage , Oils, Volatile/administration & dosage , Plant Oils/administration & dosage , Animals , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/toxicity , Camphanes , Carcinoma, Ehrlich Tumor/physiopathology , Cell Cycle Checkpoints/drug effects , Cell Proliferation/drug effects , Female , Humans , Mice , Norbornanes/chemistry , Norbornanes/toxicity , Oils, Volatile/chemistry , Oils, Volatile/toxicity , Plant Oils/chemistry , Plant Oils/toxicity
4.
Pharm Biol ; 54(12): 3093-3102, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27558915

ABSTRACT

CONTEXT: The genus Xylopia L. (Annonaceae) includes aromatic plants that have both nutritional and medicinal uses. Essential oils of Xylopia species have antitumour effects. However, the efficacy of the essential oil from the fruit of Xylopia langsdorffiana St. Hil & Tul. (EOX) has not been examined. OBJECTIVE: EOX was evaluated to determine its chemical composition, antitumour activity and toxicity. MATERIALS AND METHODS: EOX was obtained from fresh fruits of X. langsdorffiana subjected to hydrodistillation, and gas chromatography-mass spectrometry was used to characterize the chemical composition of EOX. The toxicity of EOX was evaluated using haemolysis, acute toxicity and micronucleus assays. The in vitro antitumour activity of EOX was investigated using the sulforhodamine B assay. The sarcoma 180 murine tumour model was used to evaluate the in vivo antitumour activity and toxicity of EOX (50 and 100 mg/kg) after 7 d of treatment. RESULTS: The major components of EOX were α-pinene (34.57%) and limonene (31.75%). The HC50 (concentration producing 50% haemolysis) was 293.6 µg/ml. EOX showed greater selectivity for the leukaemia cell line K562, with total growth inhibition (TGI) (concentration producing TGI) of 1.8 µg/ml, and for multidrug-resistant ovarian tumour cell line NCI/ADR-RES (TGI of 45.4 µg/ml). The LD50 was approximately 351.09 mg/kg. At doses of 50 and 100 mg/kg, EOX inhibited the in vivo growth of sarcoma 180 by 38.67 and 54.32%, respectively. EOX displayed minor hepatic alterations characteristic of acute hepatitis and induced no genotoxicity. CONCLUSION: EOX showed in vitro and in vivo antitumour activity and low toxicity, which warrants further pharmacological studies.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , DNA Damage/drug effects , Fruit , Oils, Volatile/pharmacology , Xylopia , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Cell Proliferation/drug effects , Cell Proliferation/physiology , DNA Damage/physiology , Dose-Response Relationship, Drug , Female , HT29 Cells , Humans , K562 Cells , MCF-7 Cells , Male , Mice , Oils, Volatile/isolation & purification , Xenograft Model Antitumor Assays/methods
5.
Exp Biol Med (Maywood) ; 241(5): 519-26, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26746900

ABSTRACT

Pradosia huberi is a species found in the Amazon region and used as an antiulcerogenic and gastroprotective agent; however, phytochemical analysis has revealed the presence of compounds with potential toxic effects on the reproductive system. For the evaluation of the toxicity of P. huberi on male fertility, male Wistar rats were divided into four groups: one control (distilled water p.o.) and three treated (hydroalcoholic extract of the stem bark of P. Huberi (PH-HAE) at doses of 1.22, 6.1, and 30.5 mg/kg p.o.) once daily, for 63 days. In the last week of treatment (from the 57th to the 63rd day), the rats were mated with untreated virgin females (n = 30/group) and were killed on day 64. To investigate the toxic potential of PH-HAE on the reproductive system of rats the following parameters were evaluated: sperm production, genotoxicity, and general development. The production of gametes and their morphology did not differ between control and treated groups. Treatment with PH-HAE did not result in fewer vaginal plugs formed, indicating that the ability to mate was not impaired, but caused an increase of 14.3 and 10.8% in the preimplantation loss index, a reduction of 14.3 and 10.8% in the implantation index, and a reduction of 5.6 and 8.2% in the postimplantation loss index of female rats mated with rats treated with 6.1 and 30.5 mg/kg, respectively, indicating a possible toxic action of PH-HAE on the reproductive system of rats.


Subject(s)
Genitalia, Male/drug effects , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Sapotaceae/chemistry , Animals , Female , Fertility/drug effects , Male , Rats, Wistar , Spermatogenesis/drug effects
6.
ScientificWorldJournal ; 2014: 953451, 2014.
Article in English | MEDLINE | ID: mdl-25401162

ABSTRACT

Cancer is a complex genetic disease that is a major public health problem worldwide, accounting for about 7 million deaths each year. Many anticancer drugs currently used clinically have been isolated from plant species or are based on such substances. Accumulating data has revealed anticancer activity in plant-derived monoterpenes. In this review the antitumor activity of 37 monoterpenes found in essential oils is discussed. Chemical structures, experimental models, and mechanisms of action for bioactive substances are presented.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Monoterpenes/isolation & purification , Oils, Volatile/isolation & purification , Plant Extracts/isolation & purification , Animals , Antineoplastic Agents, Phytogenic/chemistry , Humans , Monoterpenes/chemistry , Oils, Volatile/chemistry , Plant Extracts/chemistry
7.
Molecules ; 17(8): 9573-89, 2012 Aug 10.
Article in English | MEDLINE | ID: mdl-22885357

ABSTRACT

Trachylobane-360 (ent-7α-acetoxytrachyloban-18-oic acid) was isolated from Xylopia langsdorffiana. Studies have shown that it has weak cytotoxic activity against tumor and non-tumor cells. This study investigated the in vitro and in vivo antitumor effects of trachylobane-360, as well as its cytotoxicity in mouse erythrocytes. In order to evaluate the in vivo toxicological aspects related to trachylobane-360 administration, hematological, biochemical and histopathological analyses of the treated animals were performed. The compound exhibited a concentration-dependent effect in inducing hemolysis with HC50 of 273.6 µM, and a moderate in vitro concentration-dependent inhibitory effect on the proliferation of sarcoma 180 cells with IC50 values of 150.8 µM and 150.4 µM, evaluated by the trypan blue exclusion test and MTT reduction assay, respectively. The in vivo inhibition rates of sarcoma 180 tumor development were 45.60, 71.99 and 80.06% at doses of 12.5 and 25 mg/kg of trachylobane-360 and 25 mg/kg of 5-FU, respectively. Biochemical parameters were not altered. Leukopenia was observed after 5-FU treatment, but this effect was not seen with trachylobane-360 treatment. The histopathological analysis of liver and kidney showed that both organs were mildly affected by trachylobane-360 treatment. Trachylobane-360 showed no immunosuppressive effect. In conclusion, these data reinforce the anticancer potential of this natural diterpene.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Diterpenes/pharmacology , Sarcoma 180/drug therapy , Xylopia/chemistry , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/chemistry , Body Weight/drug effects , Cell Survival/drug effects , Diterpenes/administration & dosage , Diterpenes/chemistry , Dose-Response Relationship, Drug , Female , Hematologic Tests , Hemolysis/drug effects , Inhibitory Concentration 50 , Mice , Organ Size/drug effects , Sarcoma 180/pathology , Transplantation, Homologous , Tumor Burden/drug effects
8.
Rev. enferm. UFPE on line ; 4(4): 1639-1642, out.-dez. 2010. ilus
Article in Portuguese | BDENF - Nursing | ID: biblio-1032994

ABSTRACT

Objetivo: avaliar a atividade biológica dos extratos de Pithecellobium cochliocarpum, Momordica charantia e Ipomoeaasarifolia isolados e associados através do bioensaio com Artemia salina. Método: prepararam-se soluções de diferentesconcentrações dos extratos e a elas foram adicionados metanáuplios de Artemia salina. Cada concentração foi testada emtriplicata, repetida em dois experimentos. Deixou-se o conjunto em incubação sob luz artificial por 24 h e após esseperíodo realizou-se a contagem do número de larvas vivas e mortas. Determinou-se a CL50 de acordo com o métodoestatístico de Probitos. Resultados: o valor da CL50 obtido para os extratos de Pithecellobium cochliocarpum, Momordicacharantia e Ipomoea asarifolia quando testados isoladamente foi de: 543,5 ppm, 400,9 ppm e 916,3 ppm,respectivamente. Para a associação de Pithecellobium cochliocarpum e Momordica charantia, Pithecellobiumcochliocarpum e Ipomoea asarifolia, e Momordica charantia e Ipomoea asarifolia, a CL50 encontrada foi, respectivamente:641,0 ppm, 502,2 ppm e 706,4 pppm. Já a associação dos três extratos apresentou uma CL50 de 990,8 ppm. Conclusão:Todos os extratos apresentaram atividade biológica frente Artemia salina. E suas associações podem levar à interaçõesentre seus constituintes. Estudos farmacológicos mais aprofundados devem ser realizados.


Subject(s)
Animals , Artemia , Plants, Medicinal , Plants, Medicinal/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...